CDA CPG logo menu
  • Become a Member
  • Order Resources
  • Home
  • About
  • Contact
  • DONATE

The Canadian Diabetes Association has become Diabetes Canada*

CDA CPG logo
  • Guidelines
  • 2022 Updates
  • 2021 Updates
  • 2020 Updates
  • Full Guidelines
  • Appendices
  • Quick Reference Guide
  • Slides
  • Videos
  • Get the App
  • Key Messages
  • Reduce Complications
  • Keep People Safe
  • Self-management
  • For Health-Care Providers
  • Tools & Resources
  • Webinars
  • Case Studies
  • For People with Diabetes
  • Financial Support and Services
  • Tools & Resources
  • Videos
  • Other Languages
  • Ressources françaises
  • 中文資源
  • Links
  • Terms of Use
  • Citations
  • Site Map
  • orders.diabetes.ca
  • diabetes.ca
  • diabetes365.ca
  • LinedInFacebookTwitterInstagramYouTube

Appendices

New 2018 Guidelines

2018 Guidelines

Appendix 1 Diabetes Canada Diabetes Charter
Appendix 2 Etiologic Classification of Diabetes Mellitus
Appendix 3 Sample Diabetes Patient Care Flow Sheet for Adults
Appendix 4 Smarter Step Count Prescription
Appendix 5 Self-Monitoring of Blood Glucose (SMBG) Recommendation Tool for Health-Care Providers
Appendix 6 Types of Insulin
Appendix 7 Therapeutic Considerations for Renal Impairment
Appendix 8 Sick-Day Medication List
Appendix 9 Examples of Insulin Initiation and Titration Regimens in People With Type 2 Diabetes
Appendix 10 Sample Diabetes and Driving Assessment Form
Appendix 11A Rapid Screening for Diabetic Neuropathy Using the 10 g Semmes-Weinstein Monofilament
Appendix 11B Rapid Screening for Diabetic Neuropathy Using the 128 Hz Vibration Tuning Fork (the “On-Off” Method)
Appendix 12 Monofilament Testing in the Diabetic Foot
Appendix 13 Diabetes and Foot Care: A Checklist
Appendix 14 Diabetic Foot Ulcers – Essentials of Management
Appendix 15 Glycated Hemoglobin Conversion Chart

*The Canadian Diabetes Association is the registered owner of the name Diabetes Canada. All content on guidelines.diabetes.ca, CPG Apps and in our online store remains exactly the same. For questions, contact communications@diabetes.ca.